Assignee
EMERALD HEALTH PHARMACEUTICALS INC
US·1 granted patent·4 pending applications·0 citations·filing 2017–2021
Top patents by PatentIndex Score
5 records- 0150US2021317070A1Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activityEMERALD HEALTH PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0246US10919843B2Cannabidiol derivatives as inhibitors of the HIF prolyl hydroxylases activityEMERALD HEALTH PHARMACEUTICALS INC·Filed 2017·Granted Feb 16, 2021·0 cites·6 claims
- 0344US2023137092A1Composition and Method for the Treatment and Prevention of Cardiac, Pulmonary, Dermal, and Renal FibrosisEMERALD HEALTH PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0440US2022041538A1Cannabigerol quinone acid and salts thereofEMERALD HEALTH PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0532US2022184003A1Formulations of Cannabidiol Derivatives and Their Use as Modulators of Cannabinoid Receptor Type 2 (CB2)EMERALD HEALTH PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMERALD HEALTH PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →